Kato Rans

2PUBLICATIONS
1CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 07, 2024
The impact of progression-directed therapy on survival in metastatic castration-refractory prostate cancer: MEDCARE phase 3 trial.

Kato Rans, Karolien Goffin, Steven Joniau

|Dec 12, 2022
SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?

Kato Rans, Berghen Charlien, Ameye Filip

Pageof 1

Frequent Collaborators

1 joint publications

Gert De Meerleer